Industry

– EFFICACY: In the pivotal Phase 3 clinical trial program, VTAMA cream met all primary and secondary endpoints and demonstrated highly statistically significant improvement versus vehicle in Physician Global Assessment (PGA) score with 36% of patients versus 6% in vehicle in PSOARING 1 and 40% of patients versus 6% in vehicle in PSOARING 2 achieving … [Read more…]

First approval of a dry powder inhaler for treatment of PAH and PH-ILD DPI device represents a convenient option for administration of treprostinil therapy Commercial launch activities underway; patient availability expected in June 2022 SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that the … [Read more…]

CAMBRIDGE, England–(BUSINESS WIRE)–CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single- and multi-organ microphysiological systems (MPS), today announced the appointment of Dr Paul Brooks as Chief Business Officer. Key to the next stage of the Company’s growth, Paul will be responsible for shaping the company’s commercial business strategy and leading the expansion … [Read more…]

LONDON–(BUSINESS WIRE)–Digital disruptor in healthcare, Certific, expands its technology platform, enabling healthcare providers to undertake remote medical-testing, and scale the service to more patients. Starting with the launch of its Urinary Tract Infection (UTI) digital screening service, Certific’s process guides the patient through simple certified procedures, so that medical professionals can focus on more complex … [Read more…]

LONDON–(BUSINESS WIRE)–HIMSS (Healthcare Information and Management Systems Society) is bringing together healthcare and IT leaders who are navigating an extraordinary opportunity to advance the digital transformation of Europe’s health systems. Major changes prompted by the COVID-19 pandemic — including billions of euros invested in healthcare modernization, national regulatory initiatives and the proposed EU legislation for … [Read more…]

Data presentations include review of the VE303 Phase 2 CONSORTIUM study, in which VE303 was well tolerated and highly active at preventing Clostridioides difficile infection recurrence in subjects at high risk of recurrence Further CONSORTIUM study analysis shows that the VE303 high dose led to more robust colonization, which in turn correlated with prevention of … [Read more…]

Data presentations include review of the VE303 Phase 2 CONSORTIUM study, in which VE303 was well tolerated and highly active at preventing Clostridioides difficile infection recurrence in subjects at high risk of recurrence Further CONSORTIUM study analysis shows that the VE303 high dose led to more robust colonization, which in turn correlated with prevention of … [Read more…]

Proceeds to Enable Commercialization and Scale-Up of Unique RNA Sequencing Technology LAUSANNE, Switzerland–(BUSINESS WIRE)–Alithea Genomics, a fast-growing, emerging leader in the field of RNA sequencing and transcriptomics analysis, announced today the closing of a CHF 1 million seed financing round led by the Novalis Biotech Acceleration fund, with participation of Swiss-based private investors. Alithea has … [Read more…]

Granted by the United States Patent and Trademark Office, with extensions filed globally, the patent covers an approach that gives laboratories the ability to increase productivity for time and cost efficiencies. GOTHENBURG, Sweden–(BUSINESS WIRE)–#Biosero–Biosero, Inc., a BICO company and developer of laboratory automation solutions to orchestrate scientific discoveries, announced the issuance of a key patent … [Read more…]

OXFORD, England–(BUSINESS WIRE)–Beckley Psytech, a private company dedicated to addressing neurological and psychiatric disorders through the novel application of psychedelic medicines, has today announced the appointment of Dr. Laura Trespidi as Chief Development Officer. Dr. Trespidi brings more than 30 years’ of experience in global pharmaceutical and biotechnology companies, across clinical product development and manufacturing, … [Read more…]